Teva Pharma (TEVA) volatility comes in after solid Q4 and outlook

Teva Pharma (NYSE: TEVA) February call option implied volatility is at 38 compared to a level of 56 from last week, March is at 31; compared to its 52-week range of 19 to 50 after solid Q4 and outlook.

You May Also Be Interested In

• Trump on Iran: we're trying to work out a deal that's fair
• Backblaze (BLZE) call put ratio 12.9 calls to 1 put with a focus on July 12.50 calls as share price up 40%
• Ishares Msci South Korea Capped Etf (EWY) call put ratio 1 call to 1.5 puts as share price down 9.3%